Results 31 to 40 of about 112,591 (320)

Refractive status and histological changes after posterior scleral reinforcement in guinea pig [PDF]

International Journal of Ophthalmology
AIM: To investigate the refractive and the histological changes in guinea pig eyes after posterior scleral reinforcement with scleral allografts. METHODS: Four-week-old guinea pigs were implanted with scleral allografts, and the changes of refraction ...
Yu-Yan Huang, Li-Yang Zhou, Guo-Fu Chen, Duo Peng, Miao-Zhen Pan, Ji-Bo Zhou, Jia Qu   +6 more
doaj   +1 more source

Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial [PDF]

, 2016
BACKGROUND: Ménière's disease is characterised by severe vertigo attacks and hearing loss. Intratympanic gentamicin, the standard treatment for refractory Ménière's disease, reduces vertigo, but damages vestibular function and can worsen hearing.
Seemungal, Barry M, Rea, P., Golding, John F, JP Harcourt (7756886), Rea, P, Harcourt, JP, Hariri, M, Agarwal, K, M Patel (7741574), Arshad, Q., Hariri, M., Q Arshad (7718309), Bronstein, Adolfo M, Bronstein, Adolfo M., Rea, Peter, AM Bronstein (7729337), Golding, J.F., P Rea (7756880), Seemungal, B.M., Bronstein, A.M., Agarwal, K., Patel, M, JF Golding (7756883), Harcourt, J.P., BM Seemungal (7738358), Golding, JF, Hariri, Mohamed, Harcourt, Jonny P, Patel, M., Seemungal, BM, Patel, Mitesh, Arshad, Q, Bronstein, AM, Arshad, Qadeer, Agarwal, Kiran, K Agarwal (7756874), M Hariri (7756877)   +36 more
core   +1 more source

Benefit with methylprednisolone in continuous pulsetherapy in progressive primary form of multiple sclerosis: study of 11 cases in 11 years Benefício do uso de pulsoterapia contínua com metilprednisolona na forma primária progressiva da esclerose múltipla: estudo de 11 casos em 11 anos

Arquivos de Neuro-Psiquiatria, 2008
Primary progressive multiple sclerosis (PPMS) is defined clinically with a progressive course from onset. There is no approved treatment for the PPMS. Methylprednisolone IV (MP) hastens the recovery from MS relapses.
Edmar A.S. de Araújo, Marcos R. Gomes de Freitas   +1 more
doaj   +1 more source

Pruritic annular and vesicular eruption on trunk and extremities

Clinical Case Reports, 2020
We report a case of linear IgA bullous dermatosis, a rare autoimmune blistering disorder that usually presents with the abrupt onset of tense bullae. We also emphasize the importance of direct immunofluorescence for the definitive diagnosis.
Dimitra Koumaki, Vasiliki Koumaki, Sotirios Boumpoucheropoulos, Alexander Katoulis, Charikleia Kouvidou, Maria Stefanidou, Panagiotis P. Bitados, Ludmila Baltaga, Orestis Miaris, George Evangelou, Sabine Elke Krueger‐Krasagakis, Konstantinos Krasagakis   +11 more
doaj   +1 more source

A case of ANA-negative systemic sclerosis treated with methylprednisolone [PDF]

JDVI (Journal of General Procedural Dermatology & Venereology Indonesia), 2019
Background: Systemic sclerosis is a multi-systemic disease characterized by excessive fibrosis, inflammation, and vasculopathy. Common clinical features include skin thickening, telangiectasias, salt and pepper skin, beak-shaped nose, and microstomy ...
Carminda P. Rogacion, Veronica S. Uy, Reynaldo L. Ugalde, Emmerson Gale S. Vista   +3 more
doaj   +1 more source

Methylprednisolone-Responsive Leptospiral Acute Pulmonary Syndrome: A Case Report

International Journal of Medical Students, 2015
Background: Leptospirosis is an infectious disease caused by the spirochete of the genus leptospira. It is thought to be the most common zoonosis globally and has a wide range of clinical presentations with pulmonary hemorrhage being one of its most ...
Iman D. Johan-Arief,, Shen H. Lee, Xin Y. Er, Ganesh Kasinathan, Naganathan Pillai   +4 more
doaj   +1 more source

Interstitial lung disease induced by apalutamide therapy for castration‐resistant prostate cancer: A report of a rare case

IJU Case Reports, 2022
Introduction Apalutamide is a new second‐generation anti‐androgen agent approved in 2019 for the treatment of metastatic, castration‐sensitive, and non‐metastatic, castration‐resistant prostate cancer.
Fumiaki Kirishima, Yoshinori Shigematsu, Kanao Kobayashi   +2 more
doaj   +1 more source

Methylprednisolone Promotes Mycobacterium smegmatis Survival in Macrophages through NF-κB/DUSP1 Pathway

Microorganisms, 2023
Background: Mycobacterium tuberculosis (M. tuberculosis) is the causative agent of tuberculosis. As an important component of host immunity, macrophages are not only the first line of defense against M.
Anlong Li, Yonglin He, Chun Yang, Nan Lu, Jiajia Bao, Sijia Gao, Felycia Fernanda Hosyanto, Xintong He, Huichao Fu, Huajian Yan, Ningyu Ding, Lei Xu   +11 more
doaj   +1 more source

Revisited Pharmacokinetic Profiles of Methylprednisolone in Plasma and Urine After Single and Multiple Oral Administrations: Relevance in Sports Drug Testing. [PDF]

Clin Pharmacokinet
Coll S, Bressan C, Monfort N, Aldea-Perona A, Carbó ML, Ventura R.   +5 more
europepmc   +3 more sources

Assessment of potential cardiotoxic side effects of mitoxantrone in patients with multiple sclerosis [PDF]

, 2005
Previous studies showed that mitoxantrone can reduce disability progression in patients with multiple sclerosis (MS). There is, however, concern that it may cause irreversible cardiomyopathy with reduced left ventricular (LV) ejection fraction (EF) and ...
Zingler, V. C., Hohlfeld, R., Strupp, M., Brandt, T., Jahn, K., Näbauer, M., Gross, A.   +6 more
core   +1 more source